I
Intensity Therapeutics Inc
NASDAQ:INTS
Intensity Therapeutics Inc
NASDAQ:INTS
Price:
7.72
USD
0.26%
Market Closed
Market Cap:
$18.4m
Cash Flow Statement
Cash Flow Statement
Intensity Therapeutics Inc
Intensity Therapeutics Inc
Currency: USD
| Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | |||||||||||
| Net Income |
(13)
|
(9)
|
(11)
|
(14)
|
(15)
|
(16)
|
(16)
|
(15)
|
(13)
|
(12)
|
|
| Stock-Based Compensation |
2
|
2
|
1
|
2
|
2
|
2
|
3
|
2
|
2
|
2
|
|
| Other Non-Cash Items |
5
|
4
|
4
|
5
|
3
|
3
|
3
|
2
|
2
|
2
|
|
| Change in Working Capital |
1
|
(3)
|
(1)
|
(2)
|
(2)
|
0
|
(2)
|
(0)
|
(1)
|
(0)
|
|
| Cash from Operating Activities |
(7)
N/A
|
(8)
-19%
|
(7)
+9%
|
(11)
-48%
|
(15)
-37%
|
(13)
+8%
|
(15)
-13%
|
(13)
+16%
|
(11)
+14%
|
(10)
+14%
|
|
| Investing Cash Flow | |||||||||||
| Other Items |
0
|
(9)
|
(6)
|
(3)
|
(3)
|
9
|
6
|
3
|
3
|
0
|
|
| Cash from Investing Activities |
0
N/A
|
(9)
N/A
|
(6)
+32%
|
(3)
+54%
|
(3)
0%
|
9
N/A
|
6
-31%
|
3
-51%
|
3
+0%
|
0
N/A
|
|
| Financing Cash Flow | |||||||||||
| Net Issuance of Common Stock |
(0)
|
17
|
(2)
|
(2)
|
(2)
|
(19)
|
4
|
4
|
9
|
16
|
|
| Net Issuance of Debt |
2
|
2
|
0
|
0
|
(0)
|
(0)
|
0
|
0
|
0
|
0
|
|
| Other |
0
|
3
|
22
|
0
|
0
|
19
|
(1)
|
(1)
|
(2)
|
(2)
|
|
| Cash from Financing Activities |
2
N/A
|
23
+927%
|
20
-10%
|
20
-1%
|
21
+1%
|
0
-98%
|
3
+604%
|
3
+11%
|
7
+116%
|
14
+98%
|
|
| Change in Cash | |||||||||||
| Net Change in Cash |
(4)
N/A
|
6
N/A
|
7
+21%
|
7
-6%
|
3
-55%
|
(4)
N/A
|
(6)
-53%
|
(7)
-9%
|
(1)
+84%
|
4
N/A
|
|
| Free Cash Flow | |||||||||||
| Free Cash Flow |
(7)
N/A
|
(8)
-19%
|
(7)
+9%
|
(11)
-48%
|
(15)
-37%
|
(13)
+8%
|
(15)
-13%
|
(13)
+16%
|
(11)
+14%
|
(10)
+14%
|
|
Switch to:
Switch to:
See Also
Discover More
